Oligonucleotide and Peptide Therapeutics Conference (TIDES USA)

Add to calender
Research

ProQR presentation
Presentation title: Unlocking the Potential of Innovative Editing Oligonucleotides (EONs) to Address Liver Originated Disorders
Presenter: Gerard Platenburg, Co-Founder and Chief Scientific Officer at ProQR
Presentation type: Oral presentation
Session: Oligonucleotide Discovery, Preclinical and Clinical
Date: May 9, 2023 at 9:30am PDT
 

You might like this

  • Press releases

    Read the latest news on our development programs, business updates and announcements. You can sign up for email alerts so you stay up to date on all things ProQR.

    Female scientist working in ProQR's laboratories

  • Our science

    Our passion lies in discovering the latest RNA technologies and translating them to life-changing treatments for people with genetic diseases.

    Axiomer RNA editing platform technology

  • About ProQR Therapeutics

    ProQR was founded by Daniel de Boer with a mission to help people living with rare genetic diseases. This remains the sole focus of our company today.

    Daniel de Boer wearing a blue suit stands with arm crossed in a laboratory setting.